Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Reference Laboratories Common Stock to be Listed On Nasdaq National Market; Company Executes National Market Listing Agreement.


Business Editors/Health & Medical Writers

ELMWOOD PARK Elmwood Park, village (1990 pop. 23,206), Cook co., NE Ill., a suburb of Chicago; inc. 1914. It is chiefly residential. , N.J.--(BUSINESS WIRE)--March 26, 2002

Bio-Reference Laboratories, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: BRLI BRLI Bio Rad Laboratories Inc ) announced today that its application to list its common stock on The Nasdaq(R) National Market has been approved.

The Company's common stock will commence trading on The Nasdaq(R) National Market on Tuesday, March 26, 2002. The BRLI ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
 will remain unchanged.

Marc Grodman, MD, President, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  and Chairman of the Board stated, "We are extremely pleased that Nasdaq(R) has accepted our listing application. We have been articulating our strategy for growth over the past two years and the markets have provided validation for our efforts. Revenues and net income are growing at an unprecedented rate and the efficiencies that have been introduced by our outstanding management team have resulted in a significant improvement of virtually all financial metrics. We have demonstrated that our ambitious business plan can be achieved. Now that we will be listed on The Nasdaq(R) National Market System, we look forward to achieving our goals of greater market visibility, increased shareholder profitability and greater flexibility to implement our strategies of growth and expansion."

The Nasdaq Stock Market Nasdaq stock market

The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies.
 lists over 4,100 companies and trades more shares per day than any other U.S. market. For more information about Nasdaq, visit the Nasdaq Web site at www.nasdaq.com or the Nasdaq Newsroom(SM) at www.nasdaqnews.com.

About Bio-Reference Laboratories, Inc.

The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complimentary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM CKM Cabibbo-Kobayashi-Maskawa (quark mixing matrix)
CKM Certified Knowledge Manager (trademark of Hudson Associates Consulting, Inc.
) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution, to physicians, that includes disease management, laboratory reporting and ordering, as well as claims eligibility and processing through CareEvolve, its web-based healthcare portal.

Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements". Statements looking forward in time are included in this release pursuant to the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein.

www.bioreference.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 26, 2002
Words:449
Previous Article:Worldport Ceases Investment in U.K. Hosting Operations.
Next Article:Acquis Consulting Selects Connected as a Best Practice to Protect Corporate Data On Laptops.
Topics:



Related Articles
Bio-Reference Labs Announces NDC Health Information Contract for CareEvolve.com.
Bio-Reference Labs Re-Enters Oncology Market; BRLI To Expand GenPath Oncology Cancer Laboratory.
BRLI Names New Medical Director to Oversee GenPath Cancer Laboratory.
Bio-Reference Laboratories Receives Riker's Island - NY - Lab Contract; Extends New York State Prison's Contract; Contracts Valued at Approximately...
Bio-Reference Laboratories, Inc. Announces Date for Second Quarter Earnings and Conference Call.
Bio-Reference Laboratories, Inc. Announces 168% Increase in Net Income for Second Quarter.
Bio-Reference Laboratories, Inc. Announces Earnings Date for First Quarter Fiscal Year 2006.
Bio-Reference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2006.
Bio-Reference Laboratories, Inc. Reports Solid Growth on Record Quarterly Revenues; Company Reports 18% Increase in Net Revenues and 93% Increase in...
Bio-Reference Laboratories, Inc. Announces Agreement to Acquire Gene-Based Testing Laboratory, Third Quarter Results and Reaffirms Guidance for Year;...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles